Antares Pharma, Inc. (ATRS)
ATRS Price and Sentiment
ATRS Latest news
Antares Pharma, Inc. (ATRS) CEO Robert Apple on Q3 2021 Results - Earnings Call Transcript
2021-11-04 17:24Antares Pharma, Inc. (ATRS) CEO Robert Apple on Q3 2021 Results - Earnings Call Transcript
Antares Pharma (ATRS) Q3 Earnings Match Estimates
2021-11-04 09:57Antares Pharma (ATRS) delivered earnings and revenue surprises of 0.00% and -0.69%, respectively, for the quarter ended September 2021. Do the numbers hold clues to what lies ahead for the stock?
Antares Pharma Reports Third Quarter 2021 Financial and Operating Results
2021-11-04 07:00Increased Revenue 20% Year-Over-Year to $48.2 Million
Antares Pharma (ATRS) Reports Next Week: What to Expect
2021-10-28 16:51Antares Pharma (ATRS) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Antares Pharma Announces Oral Presentation at the 22nd Annual Fall Scientific Meeting of SMSNA
2021-10-25 08:30EWING, N.J., Oct. 25, 2021 (GLOBE NEWSWIRE) -- Antares Pharma, Inc. (NASDAQ: ATRS) (the “Company”), a specialty pharmaceutical company, today announced that an abstract on XYOSTED®, a subcutaneous testosterone enanthate injection, was accepted as on oral presentation at the 22nd Annual Fall Scientific Meeting of SMSNA in Scottsdale, AZ on October 21-24, 2021.
Antares Pharma to Report Third Quarter 2021 Financial and Operating Results
2021-10-21 08:30EWING, N.J., Oct. 21, 2021 (GLOBE NEWSWIRE) -- Antares Pharma, Inc. (NASDAQ: ATRS) (the “Company”), a specialty pharmaceutical company, today announced it will release its third quarter 2021 financial and operating results on Thursday, November 4, 2021, before the market opens.
Antares Pharma Initiates Phase I Study For ATRS-1902 For Adrenal Crisis Rescue
2021-09-30 09:00Pharmacokinetic data results expected in 1Q 2022 Pharmacokinetic data results expected in 1Q 2022
Antares Pharma to Participate in the H.C. Wainwright 23rd Annual Global Investment Conference
2021-09-08 08:30EWING, N.J., Sept. 08, 2021 (GLOBE NEWSWIRE) -- Antares Pharma, Inc. (NASDAQ: ATRS) (“the Company”), a specialty pharmaceutical company, today announced that Robert F. Apple, President and Chief Executive Officer, will participate and host investor meetings at the H.C. Wainwright 23rd Annual Global Investment Conference being held on September 13-15, 2021.
Got $1,000? These 2 Bargain-Bin Biopharma Stocks Might Be Worth Buying
2021-08-27 10:15These healthcare stocks have their warts, but the price is right for long-term investors.
Antares Pharma's (ATRS) CEO Robert Apple on Q2 2021 Results - Earnings Call Transcript
2021-08-05 15:15Antares Pharma's (ATRS) CEO Robert Apple on Q2 2021 Results - Earnings Call Transcript